Skip to main content
BMC Women's Health logoLink to BMC Women's Health
. 2022 Mar 19;22:78. doi: 10.1186/s12905-022-01654-9

Prevalence of dysmenorrhea among reproductive age group in Saudi Women

Hanadi Bakhsh 1,3,, Eatedal Algenaimi 2, Raghad Aldhuwayhi 3, Maha AboWadaan 4
PMCID: PMC8933932  PMID: 35305636

Abstract

Background

The condition of recurrent, crampy, lower abdominal pain during menses is defined as dysmenorrhea. The study aims to assess the factors affecting the prevalence of primary and secondary dysmenorrhea among Saudi women from the reproductive age group.

Methods

A cross-sectional survey-based study recruited 1199 participants through a systematic random sampling technique. The study was carried out among the reproductive age group in Saudi women (total number of 1199) who are more than 18-year-old and less than 45-year-old in Riyadh, King Dom of Saudi Arabia, using an electronic questionnaire.

Results

The observed dysmenorrhea in the study; 1107 (92.3%) women had non-pathological dysmenorrhea (primary) while 92 (7.7%) women had pathological dysmenorrhea (secondary) respectively.

Conclusion

In the present study, the prevalence of dysmenorrhea was high among the recruited Saudi women. The study suggests the inclusion of health education programs for students at the school and university level to deal with problems associated with dysmenorrhea that limit their interference with the student’s life.

Keywords: Dysmenorrhea, Prevalence, Reproductive Age, Saudi Arabia, Women

Background

The crampy, recurrent pain in the lower abdomen during menses is defined as dysmenorrhea [1]. Dysmenorrhea is divided into two broad categories, i.e., primary and secondary dysmenorrhea. The presence of crampy, recurrent pain in the lower abdomen during menses in the absence of demonstrable disease is primary dysmenorrhea. Adolescents and young women are more likely to be diagnosed with primary dysmenorrhea, an exclusionary diagnosis. Women suffer from pain related symptoms in secondary dysmenorrhea, with a disorder accounting for symptoms like endometriosis, uterine fibroids, or adenomyosis. The significant clinical features experienced by women suffering from secondary dysmenorrhea include pain during intercourse, resistance to effective treatment, and enlarged uterus [2].

Prostaglandins play a significant role in inducing uterine contractions released from endometrial sloughing at the start of menses [3, 4]. The contractions occur at a frequency of > 4–5 per minute (high frequency) and are incoordinate and nonrhythmic. These contractions result in increased intrauterine pressures, which may even exceed 400 mmHg (ranging between 150 and 180 mmHg) [5]. There is the development of uterine ischemia and accumulation of anaerobic metabolites as uterine pressure exceeds the arterial pressure stimulating type C pain neurons that cause dysmenorrhea. The pain perception can also be determined through stretch receptors’ activation.

Dysmenorrhea is a common problem, and it is experienced by 50–90% of women in their reproductive years worldwide, describing having painful menstruation [6]. Young women with primary dysmenorrhea make the majority group of these women. Primary dysmenorrhea tends to decrease with advancing age [7]. However, secondary dysmenorrhea develops later in life [7]. The dysmenorrhea prevalence among Saudi young women ranges from 60.9 to 89.7% [813]. These studies were performed in different cities in Saudi Arabia [813]. Dysmenorrhea-associated risk factors include younger age (adolescents in particular), smoking, and stress [14, 15]. Risk reduction is accompanied by hormonal contraceptives, higher parity, and having the first childbirth at a younger age [16, 17]. The severity of dysmenorrhea ranges from mild to severe [1]. Patients with dysmenorrhea often report depressed mood, anger, eating more than usual, nausea, dizziness, headache, fatigue, diarrhoea, or constipation associated with dysmenorrhea [12].

To attain targeted intervention and timely prevalence, it is significant to understand the disease burden among the population. In a similar context, the present study aims to determine factors affecting dysmenorrhea prevalence (primary and secondary) among Saudi women from the reproductive age group. The secondary objectives of the study are as follows;

  • To determine the relationship between dysmenorrhea and intake of dairy products.

  • To determine the relationship between dysmenorrhea and exercise

  • To evaluate the effects of dysmenorrhea on the quality of life

Methods

Study design and sampling

A cross-sectional survey-based study was conducted, and the participants were recruited through a systematic random sampling technique. The study was carried out among 1199 Saudi women. Epi Info was used to calculate the sample size at a 95% confidence level.

Inclusion criteria

The inclusion criteria for the study was Saudi women aged between 18 and 45 years and visiting the private clinic to undergo gynaecological examination for dysmenorrhea problems in Riyadh, King Dom of Saudi Arabia.

Study tool

The self-administered online questionnaire was used as a study tool on Google Forms. This type of survey was easy to administer and could include many participants.

Data collection

The study took place between July and September 2020.

The questionnaire was translated into validated Arabic language and back-translated into English. The questionnaire contained many parts, including sociodemographic questions such as (age, marital status, weight, height), menses related information such as (age at menarche, duration of menstrual cycle in last 12 months, regularity of menstrual cycle, duration of the menstrual flow, number of used pads, type of dysmenorrhea) and any medical or psychological illness. Other questions included the severity of menstrual cramps and treatment, possible symptoms associated with dysmenorrhea, general assessment of dairy products intake, and the effects of dysmenorrhea on activities of daily living.

Data analysis

The data gathered from the survey were entered on a Microsoft excel sheet and then analysed using Statistical Package of Social Sciences (SPSS) version 25 (SPSS Inc., Chicago, IL, USA). Frequencies and percentages were used to represent categorical variables; while, means and standard deviations represented continuous variables. Kolmogorov–Smirnov test was used to determine the normality of the tested data. However, groups on normally distributed variables were compared through parametric tests; while, skewed data was represented through non-parametric tests. The significant association between variables was determined using the chi-square / Fisher’s exact test, considering that cell expected frequency is < 5. The mean significant differences between the patient's age and the dysmenorrhea group were determined using an independent sample t-test. The results were considered statistically significant with a P value < 0.05.

Results

Table 1 shows the demographic characteristics of 1199 women recruited in the study according to inclusion criteria. The mean age of women observed was 27.49 years, with a mean age of 12.76 years menarche. Concerning past medical history and psychological illness; 870 (72.6%) patients had not any past medical history, whereas 32 (2.7%) had irritable bowel syndrome (IBS), 35 (2.9%) had depression, and 81 (6.8%) had more than one medical or psychological illness (Table 2).

Table 1.

Demographic profile of patients (n = 1199)

Characteristics Description N (%)
Marital status Single 792 (66.1%)
Married 367 (30.6%)
Widow 7 (0.6%)
Divorced 33 (2.8%)
Age (years) Mean ± SD 27.49 ± 7.63
Age at menarche (years) Mean ± SD 12.76 ± 1.60
Weight (kg) Mean ± SD 62.50 ± 17.07
Height (cm) Mean ± SD 151.14 ± 53.09

Table 2.

Past medical history and psychological illness of patients

Characteristics Description N (%)
I don’t have any medical or psychological illness Yes 870 (72.6%)
No 329 (27.4%)
Diabetes Mellitus Yes 10 (0.8%)
No 1189 (99.2%)
IBS Yes 32 (2.7%)
No 1167 (97.3%)
Schizophrenia Yes 3 (0.3%)
No 1196 (99.7%)
Obsessive–compulsive disorder Yes 1 (0.1%)
No 1198 (99.9%)
Attention deficit hyperactivity disorder Yes 5 (0.4%)
No 1194 (99.6%)
Depression Yes 35 (2.9%)
No 1164 (97.1%)
Stress Yes 27 (2.3%)
No 1172 (97.7%)
Migraine Yes 8 (0.7%)
No 1191 (99.3%)
More than one medical or psychological illness right now Yes 81 (6.8%)
No 1118 (93.2%)

Table 3 shows a descriptive analysis of the menstrual cycle, regularity, and type of dysmenorrhea. According to it, 296 (24.7%) women had irregular menstrual cycles, and 103 (8.6%) had less than 21 days of the menstrual cycle, and 76 (6.3%) had irregular bleeding. The majority of them, 979 (81.7%), had the duration of the menstrual flow between 3 and 7 days. Around 92 (7.7%) women had pathological dysmenorrhea.

Table 3.

Descriptive analysis of menstrual cycle, regularity, and type of dysmenorrhea

Characteristics Description N (%)
Regularity of menstrual cycle Not regular 296 (24.7%)
Regular 903 (75.3%)
Duration of the menstrual cycle in the last 12 months (number of days from the first day of the menstrual cycle to the first day of the next menstrual cycle) Less than 21 days between the cycles 103 (8.6%)
Between 21 and 35 days 907 (75.6%)
More than 35 days between the cycles 113 (9.4%)
Irregular bleeding (intermenstrual bleeding) between the cycle 76 (6.3%)
The duration of the menstrual flow 2 days or less 98 (8.2%)
3–7 days 979 (81.7%)
8 days or more 122 (10.2%)
Number of used pads (≤ 2 pads/day) mild 172 (14.3%)
(3–5 pads/day) moderate 853 (71.1%)
(≥ 6 pads/day) heavy 174 (14.5%)
Type of dysmenorrhea Non-pathological cause 1107 (92.3%)
Pathological cause 92 (7.7%)

Table 4 depicts the analysis of the classification of dysmenorrhea pain, therapy and associated symptoms. Around 170 (14.2%) patients had severe pain. The majority of women, 1086 (88.4%), experienced pain in the lower abdomen, and the majority, 808 (67.4%), had pain for more than 3 days. For relieving pain, only 55 (4.6%) patients used NSAIDs only, and 747 (62.3%) patients used more than one analgesic or other alternative therapies used for relieving menstrual cramps. Considering the possible symptoms associated with dysmenorrhea, abdominal bloating is the most common single symptom that was observed among 35 (2.9%) women with dysmenorrhea, whereas, majority of them, 926 (77.2%), had more than one possible symptom associated with dysmenorrhea (Table 4).

Table 4.

Descriptive analysis of classification of dysmenorrhea pain, therapy and associated symptoms

Characteristics Description N (%)
The intensity of the pain Mild: (pain that resolves without the need for medication) 402 (33.5%)
Moderate: (pain that is resolved with simple analgesics (NSAIDs, paracetamol) 571 (47.6%)
Severe: (pain that is not relieved with simple analgesics and may interfere with usual daily activities) 170 (14.2%)
None 56 (4.7%)
The pain localisation Lower abdomen 1060 (88.4%)
Back 77 (6.4%)
Thighs 18 (1.5%)
No pain 44 (3.7%)
The beginning of the pain Before menstruation 420 (35.0%)
At the beginning of menstruation 642 (53.5%)
After the beginning of the menstruation 95 (7.9%)
No pain 42 (3.5%)
The duration of the pain 1 day 361 (30.1%)
2 days 27 (2.3%)
3 days 3 (0.3%)
 > 3 days 808 (67.4%)
The period of pain lasts for 1 day 288 (24.0%)
2 Days 452 (37.7%)
3 Days 276 (23.0%)
More than 3 days 141 (11.8%)
No pain 42 (3.5%)
Is the pain present after the end of the menstruation Yes 133 (11.1%)
No 1066 (88.9%)
Analgesics or alternative therapies used to relieve menstrual cramps (NSAID) Yes 55 (4.6%)
No 1144 (95.4%)
Analgesics or alternative therapies used to relieve menstrual cramps (Paracetamol) Yes 64 (5.3%)
No 1135 (94.7%)
Analgesics or alternative therapies used to relieve menstrual cramps (Herbal remedies) Yes 43 (3.6%)
No 1156 (96.4%)
Analgesics or alternative therapies used to relieve menstrual cramps (Hot water bag or Hot pack) Yes 30 (2.5%)
No 1169 (97.5%)
Analgesics or alternative therapies used to relieve menstrual cramps (Take Rest) Yes 17 (1.4%)
No 1182 (98.6%)
Analgesics or alternative therapies used to relieve menstrual cramps (Antispasmodics) Yes 6 (0.5%)
No 1193 (99.5%)
More than one analgesic or alternative therapies used to relieve menstrual cramps Yes 747 (62.3%)
No 452 (37.7%)
No Analgesics or alternative therapies used to relieve menstrual cramps Yes 237 (19.8%)
No 962 (80.2%)
Possible symptoms associated with dysmenorrhea (Nausea and Vomiting) Yes 29 (2.4%)
No 1170 (97.6%)
Possible symptoms associated with dysmenorrhea (Sweating) Yes 18 (1.5%)
No 1181 (98.5%)
Possible symptoms associated with dysmenorrhea (Headache) Yes 28 (2.3%)
No 1171 (97.7%)
Possible symptoms associated with dysmenorrhea (Abdominal bloating) Yes 35 (2.9%)
No 1164 (97.1%)
Possible symptoms associated with dysmenorrhea (Diarrhea) Yes 17 (1.4%)
No 1182 (98.6%)
Possible symptoms associated with dysmenorrhea (Fatigue) Yes 5 (0.4%)
No 1194 (99.6%)
Possible symptoms associated with dysmenorrhea (Dizziness) Yes 4 (0.3%)
No 1195 (99.7%)
Possible symptoms associated with dysmenorrhea (Mood swing) Yes 22 (1.8%)
No 1177 (98.2%)
More than one possible symptom associated with dysmenorrhea Yes 926 (77.2%)
No 273 (22.8%)

Table 5 displays the distribution of dysmenorrhea limitation, academic performance, exercise and diet during menstruation. The different stress level was found during menstruation, where the majority, 614 (51.2%) of the women, usually had stress. Regarding limitation during menstruation, 161 (13.4%) women with dysmenorrhea reported to have a physical limitation, and 543 (45.3%) reported to have more than one limitation. Likewise, 122 (10.2%) reported dysmenorrhea affecting their concentration aspect of academic performance, and 462 (38.5%) patients had more than one factor affecting their academic performance. Around more than 512 (42.7%) women reported changes in sleeping routine. Furthermore, 268 (22.4%) performed more than one exercise during one exercise, and 260 (21.7%) reported exercise to reduce period pain. In connection with diet, 745 (62.1%) had all types of diet during the period.

Table 5.

Distribution of dysmenorrhea limitation, academic performance, exercise and diet during menstruation

Characteristics Description N (%)
Stress level during menstruation Usually 614 (51.2%)
Often 345 (28.8%)
Occasionally 180 (15.0%)
Hardly ever 60 (5.0%)
Any limitations due to the dysmenorrhea (Physical limitation) Yes 161 (13.4%)
No 1038 (86.6%)
Any limitations due to the dysmenorrhea (Emotional limitation) Yes 88 (7.3%)
No 1111 (92.7%)
Any limitations due to the dysmenorrhea (Social functioning limitation) Yes 28 (2.3%)
No 1171 (97.7%)
Any limitations due to the dysmenorrhea (Academic performance limitation) Yes 38 (3.2%)
No 1161 (96.8%)
No limitations due to the dysmenorrhea Yes 341 (28.4%)
No 858 (71.6%)
More than one limitation due to the dysmenorrhea Yes 543 (45.3%)
No 656 (54.7%)
If the dysmenorrhea affects your academic performance, which aspects were affected (Attendance) Yes 112 (9.3%)
No 1087 (90.7%)
If the dysmenorrhea affects your academic performance, which aspects were affected (Participation) Yes 24 (2.0%)
No 1175 (98.0%)
If the dysmenorrhea affects your academic performance, which aspects were affected (Concentration) Yes 122 (10.2%)
No 1077 (89.8%)
If the dysmenorrhea affects your academic performance, which aspects were affected (Studying time) Yes 16 (1.3%)
No 1183 (98.7%)
Nothing affects academic performance due to dysmenorrhea Yes 463 (38.6%)
No 736 (61.4%)
More than one aspect of dysmenorrhea affects your academic performance Yes 462 (38.5%)
No 737 (61.5%)
Any changes in sleep hours during menstruation? None 354 (29.5%)
Yes, less than normal 333 (27.8%)
Yes, more than normal 512 (42.7%)
Are you a smoker? No 1173 (97.8%)
Yes, less than one pack a day 23 (1.9%)
Yes, more than 1 pack 3 (0.3%)
How many times a week you do exercise? 1–2 322 (26.9%)
≤ 3 297 (24.8%)
None 580 (48.4%)
Which type of exercise you did it during menstruation (A brisk walk) Yes 347 (28.9%)
No 852 (71.1%)
Which type of exercise you did it during menstruation (Jogging) Yes 1 (0.1%)
No 1198 (99.9%)
Which type of exercise you did it during menstruation (Dancing) Yes 11 (0.9%)
No 1188 (99.1%)
Which type of exercise you did it during menstruation (Biking) Yes 4 (0.3%)
No 1195 (99.7%)
Which type of exercise you did it during menstruation (Stretching various parts of the body) Yes 8 (0.7%)
No 1191 (99.3%)
Which type of exercise you did it during menstruation (Doing yoga) Yes 10 (0.8%)
No 1189 (99.2%)
No exercise during menstruation Yes 550 (45.9%)
No 649 (54.1%)
More than type of exercise you did it during menstruation Yes 268 (22.4%)
No 931 (77.6%)
Does your regular exercise reduce period pain Yes 260 (21.7%)
No 310 (25.9%)
I don't do any exercise 629 (52.5%)
How many meals you eat per day 2 times per day 734 (61.2%)
3 times per day 388 (32.4%)
4 times per day 77 (6.4%)
The major part of your diet during the menstruation is Pasta Yes 15 (1.3%)
No 1184 (98.7%)
I don't do any exercise 0 (0.0%)
The major part of your diet during the menstruation is Meat Yes 17 (1.4%)
No 1182 (98.6%)
The major part of your diet during the menstruation is Fruit Yes 25 (2.1%)
No 1174 (97.9%)
The major part of your diet during the menstruation is Eggs Yes 27 (2.3%)
No 1172 (97.7%)
The major part of your diet during the menstruation is Fish Yes 7 (0.6%)
No 1192 (99.4%)
The major part of your diet during the menstruation is Chocolate Yes 264 (22.0%)
No 935 (78.0%)
The major part of your diet during the menstruation is Dairy products Yes 61 (5.1%)
No 1138 (94.9%)
The major part of your diet during the menstruation is Vegetables Yes 38 (3.2%)
No 1161 (96.8%)
More than one diet during menstruation Yes 745 (62.1%)
No 454 (37.9%)
How many times eats dairy products per day (milk, yogurt, cheese and labanah) 1 time per day 682 (56.9%)
2 time per day 284 (23.7%)
3 time per day 51 (4.3%)
4 time per day or more 6 (0.5%)
None 176 (14.7%)
How many times did you experience dysmenorrhea pain after eating dairy products? Usually 53 (4.4%)
Often 84 (7.0%)
Occasionally 183 (15.3%)
Hardly ever 879 (73.3%)
The amount of caffeine you drink during the menstruation? 1–2 Cup 719 (60.0%)
3–4 Cup 159 (13.3%)
More than4 cups 57 (4.8%)
None 264 (22.0%)
How many times did you experience dysmenorrhea pain after caffeine drinks? Usually, 40 (3.3%)
Often 80 (6.7%)
Occasionally 192 (16.0%)
Hardly ever 887 (74.0%)

Table 6 shows no statistically significant association among age, marital status, diabetes mellitus, IBS, Schizophrenia, and OCD with primary and secondary dysmenorrhea. However, most 775 (70%) women with age less than 30 years and the majority of the single women, 729 (65.9%), had primary dysmenorrhea. Around 55 (59.8%) women who had irregular menstrual cycles had significantly secondary dysmenorrhea (P < 0.001). Similarly, there was a significant association between the menstrual cycle duration in the last 12 months and primary and secondary dysmenorrhea (P < 0.001). Here, 11 (12.0%) women with less than 21 days cycle had secondary dysmenorrhea compared to 92 (8.3%) women with less than 21 days cycle with primary dysmenorrhea. Likewise, duration of the menstruation flow was significantly associated with the type of dysmenorrhea, were among women with more than 7 days cycle, 103 (9.3%) had primary and 19 (20.7%) had secondary dysmenorrhea (P = 0.002). Moreover, around 801 (72.4%) women with primary and 52 (56.5%) with secondary dysmenorrhea significantly used 3–5 pads per day (P = 0.004).

Table 6.

Impact and Association between dysmenorrhea and clinical and demographic characteristics of patients

Characteristics Description Primary dysmenorrhea (n = 1107) Secondary dysmenorrhea (n = 92) P value
Age Mean ± SD 27.46 ± 7.65 27.95 ± 7.48 0.548
Age group < 30 775 (70.0%) 57 (62.0%) 0.228
30–40 232 (21.0%) 26 (28.3%)
 > 40 100 (9.0%) 9 (9.8%)
Marital status Single 729 (65.9%) 63 (68.5%) 0.577
Married 342 (30.9%) 25 (27.2%)
Widow 7 (0.6%) 0 (0.0%)
Divorced 29 (2.6%) 4 (4.3%)
Diabetes mellitus Yes 9 (0.8%) 1 (1.1%) 0.781
No 1098 (99.2%) 91 (98.9%)
IBS Yes 29 (2.6%) 3 (3.3%) 0.714
No 1078 (97.4%) 89 (96.7%)
Schizophrenia Yes 2 (0.2%) 1 (1.1%) 0.095
No 1105 (99.8%) 91 (98.9%)
Obsessive–compulsive disorder Yes 1 (0.1%) 0 (0.0%) 0.773
No 1106 (99.9%) 92 (100.0%)
Attention deficit hyperactivity disorder Yes 3 (0.3%) 2 (2.2%) 0.006*
No 1104 (99.7%) 90 (97.8%)
Depression Yes 33 (3.0%) 2 (2.2%) 0.659
No 1074 (97.0%) 90 (97.8%)
Stress Yes 25 (2.3%) 2 (2.2%) 0.958
No 1082 (97.7%) 90 (97.8%)
Migraine Yes 8 (0.7%) 0 (0.0%) 0.413
No 1099 (99.3%) 92 (100.0%)
More than one medical or psychological illness right now Yes 69 (6.2%) 12 (13.0%) 0.012*
No 1038 (93.8%) 80 (87.0%)
Regularity of menstrual cycle Not regular 241 (21.8%) 55 (59.8%) < 0.001*
Regular 866 (78.2%) 37 (40.2%)
Duration of menstrual cycle in the last 12 months (number of days from first day of menstrual cycle to the first day of the next menstrual cycle) Less than 21 days between the cycle 92 (8.3%) 11 (12.0%) < 0.001*
Between 21 and 35 days 865 (78.1%) 42 (45.7%)
More than 35 days between the cycle 92 (8.3%) 21 (22.8%)
Irregular bleeding (intermenstrual bleeding) between the cycle 58 (5.2%) 18 (19.6%)
The duration of the menstrual flow 2 days or less 90 (8.1%) 8 (8.7%) *0.002
3–7 days 914 (82.6%) 65 (70.7%)
8 days or more 103 (9.3%) 19 (20.7%)
Number of used pads (≤ 2 pads/day) mild 150 (13.6%) 22 (23.9%) *0.004
(3–5 pads/day) moderate 801 (72.4%) 52 (56.5%)
(≥ 6 pads/day) heavy 156 (14.1%) 18 (19.6%)

Table 7 shows a statistically significant association between the intensity of pain and primary and secondary dysmenorrhea (P = 0.006). Where majority of 539 (48.7%) women with primary dysmenorrhea had mild and 32 (34.8%) with secondary dysmenorrhea had moderate pain. Moreover, no significant association was demonstrated between the type of dysmenorrhea and pain localisation, duration and period of pain, and use of NSAIDs or paracetamols. Whereas, majority of the women with both types significantly did not use alternative therapies (hot pack) to relieve menstrual cramps (P = 0.013). There was no statistically significant association between dysmenorrhea and associated symptoms, limitation and affected academic performance (Table 8).

Table 7.

Impact and Association between dysmenorrhea and intensity of pain and its management

Characteristics Description Primary dysmenorrhea (n = 1107) Secondary dysmenorrhea (n = 92) P-value
The intensity of the pain Mild 371 (33.5%) 31 (33.7%) *0.006
Moderate 539 (48.7%) 32 (34.8%)
Severe 147 (13.3%) 23 (25.0%)
No pain 50 (4.5%) 6 (6.5%)
The pain localisation Lower abdomen 984 (88.9%) 76 (82.6%) 0.221
Back 67 (6.1%) 10 (10.9%)
Thighs 17 (1.5%) 1 (1.1%)
No pain 39 (3.5%) 5 (5.4%)
The beginning of the pain Before menstruation 392 (35.4%) 28 (30.4%) 0.602
At the beginning of menstruation 590 (53.3%) 52 (56.5%)
After the beginning of the menstruation 86 (7.8%) 9 (9.8%)
No pain 39 (3.5%) 3 (3.3%)
The duration of the pain 1 day 329 (29.7%) 32 (34.8%) 0.178
2 days 24 (2.2%) 3 (3.3%)
3 days 3 (0.3%) 0 (0.0%)
 > 3 days 751 (67.8%) 57 (62.0%)
The period of pain lasts for 1 day 272 (24.6%) 16 (17.4%) 0.943
2 Days 420 (37.9%) 32 (34.8%)
3 Days 252 (22.8%) 24 (26.1%)
More than 3 days 124 (11.2%) 17 (18.5%)
No pain 39 (3.5%) 3 (3.3%)
Is the pain present after the end of the menstruation Yes 123 (11.1%) 10 (10.9%) 0.909
No 984 (88.9%) 82 (89.1%)
Analgesics or alternative therapies used to relieve menstrual cramps (NSAID) Yes 51 (4.6%) 4 (4.3%) 0.66
No 1056 (95.4%) 88 (95.7%)
Analgesics or alternative therapies used to relieve menstrual cramps (Paracetamol) Yes 60 (5.4%) 4 (4.3%) 0.861
No 1047 (94.6%) 88 (95.7%)
Analgesics or alternative therapies used to relieve menstrual cramps (Herbal remedies) Yes 40 (3.6%) 3 (3.3%) 0.11
No 1067 (96.4%) 89 (96.7%)
Analgesics or alternative therapies used to relieve menstrual cramps (Hot water bag or Hot pack) Yes 30 (2.7%) 0 (0.0%) *0.013
No 1077 (97.3%) 92 (100.0%)
Analgesics or alternative therapies used to relieve menstrual cramps (Take Rest) Yes 13 (1.2%) 4 (4.3%) 0.407
No 1094 (98.8%) 88 (95.7%)
Analgesics or alternative therapies used to relieve menstrual cramps (Antispasmodics) Yes 5 (0.5%) 1 (1.1%) 0.943
No 1102 (99.5%) 91 (98.9%)
More than one analgesic or alternative therapies used to relieve menstrual cramps Yes 690 (62.3%) 57 (62.0%) 0.686
No 417 (37.7%) 35 (38.0%)

Table 8.

Impact and Association between dysmenorrhea and associated symptoms, limitation and effected academic performance

Characteristics Description Primary dysmenorrhea (n = 1107) Secondary dysmenorrhea (n = 92) P-value
Possible symptoms associated with dysmenorrhea (Nausea and Vomiting) Yes 28 (2.5%) 1 (1.1%) 0.387
No 1079 (97.5%) 91 (98.9%)
Possible symptoms associated with dysmenorrhea (Sweating) Yes 16 (1.4%) 2 (2.2%) 0.581
No 1091 (98.6%) 90 (97.8%)
Possible symptoms associated with dysmenorrhea (Headache) Yes 24 (2.2%) 4 (4.3%) 0.183
No 1083 (97.8%) 88 (95.7%)
Possible symptoms associated with dysmenorrhea (Abdominal bloating) Yes 33 (3.0%) 2 (2.2%) 0.659
No 1074 (97.0%) 90 (97.8%)
Possible symptoms associated with dysmenorrhea (Diarrhoea) Yes 16 (1.4%) 1 (1.1%) 0.780
No 1091 (98.6%) 91 (98.9%)
Possible symptoms associated with dysmenorrhea (Fatigue) Yes 4 (0.4%) 1 (1.1%) 0.299
No 1103 (99.6%) 91 (98.9%)
Possible symptoms associated with dysmenorrhea (Dizziness) Yes 4 (0.4%) 0 (0.0%) 0.564
No 1103 (99.6%) 92 (100.0%)
Possible symptoms associated with dysmenorrhea (Mood swing) Yes 21 (1.9%) 1 (1.1%) 0.578
No 1086 (98.1%) 91 (98.9%)
More than one possible symptom associated with dysmenorrhea Yes 856 (77.3%) 70 (76.1%) 0.785
No 251 (22.7%) 22 (23.9%)
Stress level during menstruation Usually 561 (50.7%) 53 (57.6%) 0.438
Often 325 (29.4%) 20 (21.7%)
Occasionally 165 (14.9%) 15 (16.3%)
Hardly ever 56 (5.1%) 4 (4.3%)
Any limitations due to the dysmenorrhea (Physical limitation) Yes 152 (13.7%) 9 (9.8%) 0.285
No 955 (86.3%) 83 (90.2%)
Any limitations due to the dysmenorrhea (Emotional limitation) Yes 81 (7.3%) 7 (7.6%) 0.917
No 1026 (92.7%) 85 (92.4%)
Any limitations due to the dysmenorrhea (Social functioning limitation) Yes 24 (2.2%) 4 (4.3%) 0.183
No 1083 (97.8%) 88 (95.7%)
Any limitations due to the dysmenorrhea (Academic performance limitation) Yes 37 (3.3%) 1 (1.1%) 0.235
No 1070 (96.7%) 91 (98.9%)
No limitations due to the dysmenorrhea Yes 317 (28.6%) 24 (26.1%) 0.602
No 790 (71.4%) 68 (73.9%)
More than one limitation due to the dysmenorrhea Yes 496 (44.8%) 47 (51.1%) 0.244
No 611 (55.2%) 45 (48.9%)
If the dysmenorrhea affects your academic performance, which aspects were affected (Attendance) Yes 102 (9.2%) 10 (10.9%) 0.600
No 1005 (90.8%) 82 (89.1%)
If the dysmenorrhea affects your academic performance, which aspects were affected (Participation) Yes 23 (2.1%) 1 (1.1%) 0.514
No 1084 (97.9%) 91 (98.9%)
If the dysmenorrhea affects your academic performance, which aspects were affected (Concentration) Yes 112 (10.1%) 10 (10.9%) 0.818
No 995 (89.9%) 82 (89.1%)
If the dysmenorrhea affects your academic performance, which aspects were affected (Studying time) Yes 16 (1.4%) 0 (0.0%) 0.246
No 1091 (98.6%) 92 (100.0%)
Nothing affects academic performance due to dysmenorrhea Yes 427 (38.6%) 36 (39.1%) 0.915
No 680 (61.4%) 56 (60.9%)
More than one aspect of dysmenorrhea affects your academic performance Yes 427 (38.6%) 35 (38.0%) 0.920
No 680 (61.4%) 57 (62.0%)
Any changes in sleep hours during menstruation? None 329 (29.7%) 25 (27.2%) 0.865
Yes, less than normal 306 (27.6%) 27 (29.3%)
Yes, more than normal 472 (42.6%) 40 (43.5%)
Are you a smoker? No 1086 (98.1%) 87 (94.6%) 0.051
Yes, less than one pack a day 19 (1.7%) 4 (4.3%)
Yes more than 1 pack 2 (0.2%) 1 (1.1%)
Number of cigarettes Mean ± SD 2.87 ± 1.18 6.67 ± 2.50 0.628

There was a statistically significant association between dysmenorrhea type and dietary habits, exercise and quality of life, as shown in Table 9. There was a statistically significant association between exercise during menstruation and primary and secondary dysmenorrhea (P = 0.001). It is shown that 1105 (99.8%) patients from primary and 90 (97.8%) secondary dysmenorrhea did not use bikes, respectively.

Table 9.

Impact and association between dysmenorrhea and dietary habits, exercise and quality of life

Characteristics Description Primary dysmenorrhea (n = 1107) Secondary dysmenorrhea (n = 92) P-value
How many times a week you do exercise? 1–2 299 (27.0%) 23 (25.0%) 0.832
≤ 3 272 (24.6%) 25 (27.2%)
None 536 (48.4%) 44 (47.8%)
Which type of exercise you did it during menstruation (A brisk walk) Yes 323 (29.2%) 24 (26.1%) 0.529
No 784 (70.8%) 68 (73.9%)
Which type of exercise you did it during menstruation (Jogging) Yes 1 (0.1%) 0 (0.0%) 0.773
No 1106 (99.9%) 92 (100.0%)
Which type of exercise you did it during menstruation (Dancing) Yes 11 (1.0%) 0 (0.0%) 0.337
No 1096 (99.0%) 92 (100.0%)
Which type of exercise you did it during menstruation (Biking) Yes 2 (0.2%) 2 (2.2%) *0.001
No 1105 (99.8%) 90 (97.8%)
Which type of exercise you did it during menstruation (Stretching various parts of the body) Yes 7 (0.6%) 1 (1.1%) 0.607
No 1100 (99.4%) 91 (98.9%)
Which type of exercise you did it during menstruation (Doing yoga) Yes 8 (0.7%) 2 (2.2%) 0.141
No 1099 (99.3%) 90 (97.8%)
No exercise during menstruation Yes 503 (45.4%) 47 (51.1%) 0.296
No 604 (54.6%) 45 (48.9%)
More than type of exercise you did it during menstruation Yes 252 (22.8%) 16 (17.4%) 0.234
No 855 (77.2%) 76 (82.6%)
Does your regular exercise reduce period pain Yes 243 (22.0%) 17 (18.5%) 0.701
No 284 (25.7%) 26 (28.3%)
I don't do any exercise 580 (52.4%) 49 (53.3%)
How many meals you eat per day 2 times per day 681 (61.5%) 53 (57.6%) 0.078
3 times per day 360 (32.5%) 28 (30.4%)
4 times per day 66 (6.0%) 11 (12.0%)
The major part of your diet during the menstruation is Pasta Yes 15 (1.4%) 0 (0.0%) 0.261
No 1092 (98.6%) 92 (100.0%)
The major part of your diet during the menstruation is Meat Yes 16 (1.4%) 1 (1.1%) 0.78
No 1091 (98.6%) 91 (98.9%)
The major part of your diet during the menstruation is Fruit Yes 24 (2.2%) 1 (1.1%) 0.486
No 1083 (97.8%) 91 (98.9%)
The major part of your diet during the menstruation is Eggs Yes 27 (2.4%) 0 (0.0%) 0.13
No 1080 (97.6%) 92 (100.0%)
The major part of your diet during the menstruation is Fish Yes 7 (0.6%) 0 (0.0%) 0.444
No 1100 (99.4%) 92 (100.0%)
The major part of your diet during the menstruation is Chocolate Yes 240 (21.7%) 24 (26.1%) 0.327
No 867 (78.3%) 68 (73.9%)
The major part of your diet during the menstruation is Dairy products Yes 58 (5.2%) 3 (3.3%) 0.407
No 1049 (94.8%) 89 (96.7%)
The major part of your diet during the menstruation is Vegetables Yes 35 (3.2%) 3 (3.3%) 0.958
No 1072 (96.8%) 89 (96.7%)
More than one diet during menstruation Yes 685 (61.9%) 60 (65.2%) 0.525
No 422 (38.1%) 32 (34.8%)
How many time eats dairy products per day (milk, yogurt, cheese and labanah) 1 time per day 629 (56.8%) 53 (57.6%) 0.698
2 time per day 266 (24.0%) 18 (19.6%)
3 time per day 47 (4.2%) 4 (4.3%)
4 time per day or more 6 (0.5%) 0 (0.0%)
None 159 (14.4%) 17 (18.5%)
How many times did you experience dysmenorrhea pain after eating dairy products? Usually 47 (4.2%) 6 (6.5%) 0.754
Often 78 (7.0%) 6 (6.5%)
Occasionally 168 (15.2%) 15 (16.3%)
Hardly ever 814 (73.5%) 65 (70.7%)
The amount of caffeine you drink during the menstruation? 1–2 Cup 669 (60.4%) 50 (54.3%) 0.726
3–4 Cup 145 (13.1%) 14 (15.2%)
More than4 cups 52 (4.7%) 5 (5.4%)
None 241 (21.8%) 23 (25.0%)
How many times did you experience dysmenorrhea pain after caffeine drinks? Usually 37 (3.3%) 3 (3.3%) 0.863
Often 73 (6.6%) 7 (7.6%)
Occasionally 180 (16.3%) 12 (13.0%)
Hardly ever 817 (73.8%) 70 (76.1%)

Discussion

The study aims to determine the factors affecting dysmenorrhea (primary and secondary) prevalence among Saudi women from the reproductive age group. Dysmenorrhea is an important symptom among many women of reproductive age. Dysmenorrhea has a significant impact on the health-related quality of life, work productivity, and health-care utilisation. The dysmenorrhea prevalence came out to be 95.3% in the present study. This prevalence was higher than that observed in the other studies in Saudi Arabia and worldwide [813]. The worldwide prevalence ranged from 50 to 90% [1821]. The high majority observed in this study could be due to the different population age groups included in it or that the women who had the symptoms were more interested in taking part in it.

The study also determined the relationship between dysmenorrhea and intake of dairy products, which showed no significant association. A systematic review conducted by Zahra et al. [22] found that fruits, vegetables, milk, fish and dairy products had positive associations with decreased menstrual pain in primary dysmenorrhea. However, the majority of the participants did not have fruits, vegetables, and dairy products as part of their primary diet, which could be why there was a high prevalence of dysmenorrhea in the studied population.

Also, this study had the objective to elucidate the possible relationship between exercise and dysmenorrhea and to evaluate the impact of dysmenorrhea on the quality of life. Varied researches previously have shown dysmenorrhea to be impacted by multiple factors, of these were physical and daily activities, emotional health, social activities, family and friends’ relationships, in addition to the academic performance regarding concentration, attendance, class participation, and study time [23, 24]. In this study, the impact and association between dysmenorrhea and associated symptoms, limitation and affected academic performance were not statistically significant. As most of the women included in the study reported not to have done an adequate amount of exercise, this could be another factor that the prevalence among participants was high.

Another notable finding of this study was the significant association between dysmenorrhea and irregularity of the menstrual cycle. Similarly, a survey by Ameade et al. [25] showed a statistically significant association between the severity of dysmenorrhea and irregularity of menstruation. Also, the menstrual flow and dysmenorrhea were necessary, similar to the results of previous studies [26, 27]. There was a statistically significant association between the type of dysmenorrhea and pain intensity (P = 0.006). The severity of pain was high among women with secondary dysmenorrhea compared to women with primary dysmenorrhea.

Menstrual abnormalities, dysmenorrhea, infertility, chronic pelvic pain (CPP), and dyspareunia are endometriosis's most prevalent clinical indications. Endometriosis symptoms frequently impact patients' social and psychological functioning. As a result, endometriosis is considered a debilitating disease that can jeopardise social interactions and mental health [28]. Endometriosis can be effectively treated with progestins. The effects of the etonogestrel implant on pelvic discomfort, sexual function, and quality of life in women needing long-term reversible contraception and having ovarian cysts of possible endometriotic origin are investigated in the study by Sansone et al. [29]. In patients with ovarian cysts suspected of being caused by endometriosis, etonogestrel implants appear to relieve pelvic discomfort, enhance sexual function, and improve quality of life. Endometriosis is characterised by endometrial-like tissue outside the uterus, which is accompanied by a persistent and inflammatory response. Brasil et al. [30] determined the prevalence and degrees of psychological stress among endometriosis patients. The study showed that multidisciplinary illness management should include mental health assistance inpatient care beyond pain treatment. Moreover, the medical team’s attitude toward the patients’ psychological stress may positively impact their therapy.

It is essential to encourage modifications in the diet and lifestyle of individuals like restricted intake of salt and excessive caffeinated drinks with effective exercising for reducing the severity of dysmenorrhea symptoms. The possible side effects of using analgesics also need to be informed to the women, and they need to be encouraged for other management techniques like the use of hot pads [31, 32]. Measures to deal with dysmenorrhea need to be focused at the school and university level for limiting its interference with the student’s life. Apart from these implications, there were some limitations of this study. For instance, the data was collected using self-administered questionnaires (electronic questionnaires), which decreased the reliability of the results. Moreover, the study only included females from a specific region. The study also fails to compare the sample to the number of Saudi women of reproductive age. As a result, the results just reflect a small portion of the sample. Future studies need to include females from other regions of Saudi Arabia to generalise the results to all Saudi females.

Conclusions

The present study revealed an increased prevalence of dysmenorrhea among Saudi women of reproductive age. This could be due to an unbalanced diet and a low level of exercise seen in the studied group. The intensity of pain was high among women with secondary dysmenorrhea compared to women with primary dysmenorrhea. There was no association of prevalence of dysmenorrhea with the age group or marital status. Campaigns on the information regarding dysmenorrhea and its remedies should be promoted to make the quality of life of women better that could get limited due to menstruation.

Acknowledgements

The authors would like to thank the Center for Promising Research in Social Research and Women’s Studies. Deanship of Scientific Research at Princess Nourah bint Abdulrahman University for funding this research in 2020–2021

Abbreviations

SD

Standard deviation

PNU

Princess Nourah Bint Abdulrahman

Authors' contributions

Hanadi Bakhsh - conception, analysis, drafting and methodology. Eatedal Algenaimi - drafting and methods. Raghad Aldhuwayhi - drafting and methods. Maha AboWadaan - drafting and methods.

Funding

The research is funded from the Center for Promising Research in Social Research and Women’s Studies. Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Availability of data and materials

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

The data was protected for confidentiality when conducting this study. The Institutional Review Board of PNU (Princess Nourah bint Abdulrahman University) approved this study. It was obtained before starting data collection. At the end of the questionnaire, an email was provided for any inquiries from the participants about any unclear questions. All participants were informed that participation was entirely voluntary. Additionally, no name was recorded on the questionnaires, and all of the personal information of participants will be confidentially reserved and kept safe. Informed consent was obtained from all participants All authors reviewed the manuscript and approved it. All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The author declares no competing interest.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Hanadi Bakhsh, Email: drobgyn2005@gmail.com.

Eatedal Algenaimi, Email: eatedal.gh@gmail.com.

Raghad Aldhuwayhi, Email: raghad.pnu@gmail.com.

Maha AboWadaan, Email: mahaabowadaan@gmail.com.

References

  • 1.Kho KA, Shields JK. Diagnosis and management of primary dysmenorrhea. JAMA. 2020;323:268–269. doi: 10.1001/jama.2019.16921. [DOI] [PubMed] [Google Scholar]
  • 2.Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21:762–778. doi: 10.1093/humupd/dmv039. [DOI] [PubMed] [Google Scholar]
  • 3.Fajrin I, Alam G, Usman AN. Prostaglandin level of primary dysmenorrhea pain sufferers. Enferm Clin. 2020;30:5–9. doi: 10.1016/j.enfcli.2019.07.016. [DOI] [Google Scholar]
  • 4.Smith RP. The role of prostaglandins in dysmenorrhea and menorrhagia. In: Dysmenorrhea and Menorrhagia. 1st ed. Boca Raton: Springer. 2018:75–88.
  • 5.Najimudeen M, Myint MH, Masharudin AW. Reappraisal on the Management of Primary Dysmenorrhoea in Adolescents. Sch Int J Obstet Gynec. 2020;192–9. 10.36348/sijog.2020.v03i09.001
  • 6.Al-Jefout M, Nawaiseh N. Continuous norethisterone acetate versus cyclical drospirenone 3 mg/Ethinyl estradiol 20 μg for the management of primary dysmenorrhea in young adult women. J Pediatr Adolesc Gynecol. 2016;29:1437. doi: 10.1016/j.jpag.2015.08.009. [DOI] [PubMed] [Google Scholar]
  • 7.Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th ed. Lippincott Williams & Wilkins. 2005.
  • 8.Ibrahim NK, Al-Sharabi BM, Al-Asiri RA, Alotaibi NA, Al-Husaini WI, Al-Khajah HA, Rakkah RM, Turkistani AM. Dysmenorrhea among female medical students in King Abdulaziz University Prevalence, Predictors and outcome. Pak J Med Sci. 2015;31:1312. doi: 10.12669/pjms.316.8752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rafique N, Al-Sheikh MH. Prevalence of menstrual problems and their association with psychological stress in young female students studying health sciences. Saudi Med J. 2018;39:67. doi: 10.15537/smj.2018.1.21438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rafique N, AlSheikh MH. Prevalence of menstrual problems and their association with psychological stress in young female students studying health sciences. Saudi Med J. 2018;39:67–73. doi: 10.15537/smj.2018.1.21438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Abd El-Mawgod MM, Alshaibany AS, Al-Anazi AM. Epidemiology of dysmenorrhea among secondary-school students in Northern Saudi Arabia. J Egypt Public Health Assoc. 2016;91:115–9. doi: 10.1097/01.EPX.0000489884.20641.95. [DOI] [PubMed] [Google Scholar]
  • 12.Saleem MA. Dysmenorrhea, associated symptoms, and management among students at King Khalid University, Saudi Arabia: An exploratory study. J Family Med Prim Care. 2018;7:769. doi: 10.4103/jfmpc.jfmpc_113_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hashim RT, Alkhalifah SS, Alsalman AA, Alfaris DM, Al-Hussaini MA, Qasim RS, Shaik SA. Prevalence of primary dysmenorrhea and its effect on the quality of life amongst female medical students at King Saud University, Riyadh. Saudi Arabia. Saudi Med J. 2020;41:283–9. doi: 10.15537/smj.2020.3.24988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36:104. doi: 10.1093/epirev/mxt009. [DOI] [PubMed] [Google Scholar]
  • 15.Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. J Obstet Gynaecol Can. 2017;39:585–95. doi: 10.1016/j.jogc.2016.12.023. [DOI] [PubMed] [Google Scholar]
  • 16.Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol. 1982;144:655–660. doi: 10.1016/0002-9378(82)90433-1. [DOI] [PubMed] [Google Scholar]
  • 17.Campbell MA, McGrath PJ. Use of medication by adolescents for the management of menstrual discomfort. Arch Pediatr Adolesc Med. 1997;151:905–913. doi: 10.1001/archpedi.1997.02170460043007. [DOI] [PubMed] [Google Scholar]
  • 18.Hailemeskel S, Demissie A, Assefa N. Primary dysmenorrhea magnitude, associated risk factors, and its effect on academic performance: evidence from female university students in Ethiopia. Int J Women's Health. 2016;2016(8):489–496. doi: 10.2147/IJWH.S112768.eCollection. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Subasinghe AK, Happo L, Jayasinghe YL, Garland SM, Gorelik A, Wark JD. Prevalence and severity of dysmenorrhoea, and management options reported by young Australian women. Aust Fam Physician. 2016;45:829–834. [PubMed] [Google Scholar]
  • 20.Habibi N, Huang MSL, Gan WY, Zulida R, Safavi SM. Prevalence of primary dysmenorrhea and factors associated with its intensity among undergraduate students: a cross-sectional study. Pain Manag Nurs. 2015;16:855–861. doi: 10.1016/j.pmn.2015.07.001. [DOI] [PubMed] [Google Scholar]
  • 21.Ortiz MI. Primary dysmenorrhea among Mexican university students: prevalence, impact and treatment. Eur J Obstet Gynecol Reprod Biol. 2010;152:73–77. doi: 10.1016/j.ejogrb.2010.04.015. [DOI] [PubMed] [Google Scholar]
  • 22.Bajalan Z, Alimoradi Z, Moafi F. Nutrition as a potential factor of primary dysmenorrhea: a systematic review of observational studies. Gynecol Obstet Invest. 2019;84:209–224. doi: 10.1159/000495408. [DOI] [PubMed] [Google Scholar]
  • 23.Al-Jefout M, Seham AF, Jameel H, Randa AQ, Luscombe G. Dysmenorrhea: prevalence and impact on quality of life among young adult Jordanian females. J Pediatr Adolesc Gynecol. 2015;28:173–185. doi: 10.1016/j.jpag.2014.07.005. [DOI] [PubMed] [Google Scholar]
  • 24.Hailemeskel S, Demissie A, Assefa N. Primary dysmenorrhea magnitude, associated risk factors, and its effect on academic performance: evidence from female university students in Ethiopia. Int J Women's Health. 2016;8:489–496. doi: 10.2147/IJWH.S112768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ameade EP, Amalba A, Mohammed BS. Prevalence of dysmenorrhea among University students in Northern Ghana; its impact and management strategies. BMC Womens Health. 2018;18:1–9. doi: 10.1186/s12905-018-0532-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Al-Matouq S, Al-Mutairi H, Al-Mutairi O, Abdulaziz F, Al-Basri D, Al-Enzi M, Al-Taiar A. Dysmenorrhea among high-school students and its associated factors in Kuwait. BMC Pediatr. 2019;19:80. doi: 10.1186/s12887-019-1442-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tomás-Rodríguez MI, Palazon-Bru A, Martínez-St John DR, Navarro-Cremades F, Toledo-Marhuenda JV, Gil-Guillén VF. Factors associated with increased pain in primary dysmenorrhea: analysis using a multivariate ordered logistic regression model. J Pediatr Adolesc Gynecol. 2017;30:199–202. doi: 10.1016/j.jpag.2016.09.007. [DOI] [PubMed] [Google Scholar]
  • 28.Laganà AS, La Rosa VL, Rapisarda AM, Valenti G, Sapia F, Chiofalo B, Rossetti D, Frangež HB, Bokal EV, Vitale SG. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Women's Health. 2017;9:323. doi: 10.2147/IJWH.S119729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sansone A, De Rosa N, Giampaolino P, Guida M, Laganà AS, Di Carlo C. Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study. Arch Gynecol Obstet. 2018;298:731–736. doi: 10.1007/s00404-018-4851-0. [DOI] [PubMed] [Google Scholar]
  • 30.Brasil DL, Montagna E, Trevisan CM, La Rosa VL, Lagana AS, Barbosa CP, Bianco B, Zaia V. Psychological stress levels in women with endometriosis: systematic review and meta-analysis of observational studies. Minerva Med. 2019;111:90–102. doi: 10.23736/S0026-4806.19.06350-X. [DOI] [PubMed] [Google Scholar]
  • 31.Aksu H, Özsoy S. Primary dysmenorrhea and herbals. J Health Commun. 2016;1:23. doi: 10.4172/2472-1654.100023. [DOI] [Google Scholar]
  • 32.Savitha V, Roopa D, Sridhara KM. A study to assess the effectiveness of structured teaching programme on knowledge regarding home remedies on reducing dysmenorrhea among adolescent girls at St. Paul’s girls High school. Davangere. Asian J Nurs Edu Res. 2016;6:327–30. doi: 10.5958/2349-2996.2016.00061.6. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.


Articles from BMC Women's Health are provided here courtesy of BMC

RESOURCES